
|Articles|January 6, 2003
Industry insiders continue to spar over Waxman-Hatch Act
Debate between brand and generic drug companies contues to rage over whether the Waxman-Hatch Act should be overhauled.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
4
Pharmacists’ Expanding Roles in Diabetes, Community Health Care
5




















































































































































